Fig. 2From: Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDAMean (SD) normalised weights assigned to each quantitative criterion by the French (a), Italian (b), Spanish panels (c) using the 5-point direct weight elicitation techniqueBack to article page